Leading epigenome editing company Tune Therapeutics announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and Hevolution...
Tune Therapeutics, a biotechnology company pioneering the creation of epi-therapeutic medicines, launched with its powerful and precise genetic tuning platform, TEMPO. This cutting-edge technology...